While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β 2 glycoprotein I (anti-
β 2 GPI) antibodies represent the best available and the most widely used tests in the …

Seminars in Thrombosis and Hemostasis on the topic of antiphospholipid antibodies (aPL)
and the antiphospholipid syndrome (APS). The first issue dealt with the pathogenesis …

The antiphospholipid syndrome (APS) is a multi-system prothrombotic disorder associated
with circulating auto-antibodies directed against various phospholipid-binding proteins. The …

Thrombosis and Hemostasis on the topic of antiphospholipid (aPL) antibodies and the
antiphospholipid syndrome (APS). The next issue will deal with the limitations …

The presence of antiphospholipid antibodies (aPL) combined with venous or arterial
thrombosis, and/or obstetric complications defines the antiphospholipid syndrome (APS) …

Antiphospholipid antibodies (aPL) constitute a heterogeneous group of autoantibodies that
share the ability to bind phospholipids (PL) alone, protein-PL complexes, or PL-binding …

Venous and arterial thromboses are the most clinically relevant manifestations of the
Antiphospholipid S yndrome (APS)(1), whose laboratory hallmark is represented by the …

Classification criteria for antiphospholipid syndrome (APS) require IgG or IgM isotypes of the
anticardiolipin (aCL) antibodies, anti-β2 glycoprotein I (anti-β2GPI) antibodies, and/or the …

Background: The antiphospholipid syndrome (APS) is an important cause of acquired
thromboembolic complications and pregnancy morbidity. Its diagnosis is based on clinical …

Most autoantibodies associated with the antiphospholipid (aPL) syndrome and detected in
standard anticardiolipin and/or lupus anticoagulant assays are directed against β2 …